<DOC>
	<DOC>NCT00389220</DOC>
	<brief_summary>The purpose of this study is to compare the BioMatrix Flex (Biolimus A9-Eluting) stent system with the Cypher SELECT (Sirolimus-Eluting) stent system in a non-inferiority trial.</brief_summary>
	<brief_title>Limus Eluted From A Durable Versus ERodable Stent Coating</brief_title>
	<detailed_description>Compare the safety and efficacy of the BioMatrix Flex (Biolimus A9-Eluting) stent system with the Cypher SELECT (Sirolimus-Eluting) stent system in a prospective, multi-center, randomized, controlled, non-inferiority trial in patients undergoing percutaneous coronary intervention in routine clinical practice.</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>Age &gt;= 18 years; Symptomatic coronary artery disease including patients with chronic stable angina, silent ischemia, and acute coronary syndromes including nonST elevation myocardial infarction and STelevation myocardial infarction; Presence of one or more coronary artery stenoses &gt;50% in a native coronary artery or a saphenous bypass graft from 2.25 to 3.5 mm in diameter that can be covered with one or multiple stents; No limitation on the number of treated lesions, and vessels, and lesion length Pregnancy; Known intolerance to aspirin, clopidogrel, heparin, stainless steel, Sirolimus, Biolimus or contrast material; Inability to provide informed consent; Currently participating in another trial before reaching first endpoint; Planned surgery within 6 months of PCI unless dual antiplatelet therapy is maintained throughout the perisurgical period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Coronary Disease</keyword>
	<keyword>Coronary Stenosis</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Coronary Restenosis</keyword>
	<keyword>Drug Eluting Stent</keyword>
</DOC>